Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


First published on February 17, 2009
This version was published on January 1, 2009
Neuro Oncol 2009 11(4):348-356; DOI:10.1215/15228517-2009-001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/4/348    most recent
15228517-2009-001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Everhard, S.
Right arrow Articles by Thillet, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Basic and Translational Investigations

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

Sibille Everhard, Jörg Tost, Hafida El Abdalaoui, Emmanuelle Crinière, Florence Busato, Yannick Marie, Ivo G. Gut, Marc Sanson, Karima Mokhtari, Florence Laigle-Donadey, Khê Hoang-Xuan, Jean-Yves Delattre and Joëlle Thillet

French National Institute for Health and Medical Research (INSERM), Paris (S.E., E.C., Y.M., M.S., F.L.-D., K.H.-X., J.-Y.D., J.T.); Université Pierre and Marie Curie, Faculté de Médecine, Hôpital de la Pitié-Salpétrière, Paris (S.E., E.C., Y.M., M.S., K.M., F.L.-D., K.H.-X., J.-Y.D., J.T.); Laboratory for Epigenetics, Centre National de Génotypage, Commissariat à l'Énergie Atomique, Institut de Génomique, Evry (J.T., H.E.A., F.B., I.G.G.); Assistance Publique–Hôpitaux de Paris, Hôpital de la Pitié-Salpétrière, Service de Neurologie Mazarin, Paris (M.S., K.M., F.L.-D., K.H.-X., J.-Y.D.); France

Address correspondence to Sibille Everhard, INSERM, U711, Batiment de la nouvelle Pharmacie, 47 Bd de l'Hôpital, 75651 Paris cedex 13, France (everhard{at}ccr.jussieu.fr).

The O6-methylguanine-DNA methyltransferase gene (MGMT) is methylated in several cancers, including gliomas. However, the functional role of cysteine-phosphate-guanine (CpG) island (CGI) methylation in MGMT silencing is still controversial. The aim of this study was to investigate whether MGMT CGI methylation correlates inversely with RNA expression of MGMT in glioblastomas and to determine the CpG region whose methylation best reflects the level of expression. The methylation level of CpG sites that are potentially related to expression was investigated in 54 glioblastomas by pyrosequencing, a highly quantitative method, and analyzed with respect to their MGMT mRNA expression status. Three groups of patients were identified according to the methylation pattern of all 52 analyzed CpG sites. Overall, an 85% rate of concordance was observed between methylation and expression (p < 0.0001). When analyzing each CpG separately, six CpG sites were highly correlated with expression (p < 0.0001), and two CpG regions could be used as surrogate markers for RNA expression in 81.5% of the patients. This study indicates that there is good statistical agreement between MGMT methylation and expression, and that some CpG regions better reflect MGMT expression than do others. However, if transcriptional repression is the key mechanism in explaining the higher chemosensitivity of MGMT-methylated tumors, a substantial rate of discordance should lead clinicians to be cautious when deciding on a therapeutic strategy based on MGMT methylation status alone.

Key Words: CpG island methylation • expression • glioblastomas • MGMT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2009 by Society for Neuro-Oncology